Memantine (Namenda) just got approved for Alzheimer's

November 2003

Memantine (Namenda) just got approved for Alzheimer's.

It's been used for years in Europe as brand-name Ebixa. It'll hit U.S. pharmacies Jan '04. There will be a HUGE demand.

Memantine is approved for moderate to SEVERE Alzheimer's.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

who should take a daily aspirin...and how much they should take
Alzheimer's Disease Memantine (Namenda) just got approved for Alzheimer's
Cardiology new warnings about a potential interaction between cranberry juice and warfarin
Cardiology More heart failure patients will be taking an aldosterone antagonist
Osteoporosis thiazide diuretics reduce the risk of fractures from osteoporosis
Osteoporosis combo treatment for osteoporosis in postmenopausal women
Shingles Does the chickenpox vaccine (Varivax) prevent shingles?
new protease inhibitor called Lexiva
Infectious Diseases antibiotic suspensions that DON'T need refrigeration...DisperMox and Panixine Disperdose
Infectious Diseases new injectable antibiotic called Cubicin
Hematology & Oncology Femara (letrozole) to prevent recurrent breast cancer
Men's Health Levitra will work in some men who don't respond to Viagra
possible link between atypical antipsychotics and diabetes
Zomig NASAL SPRAY
confusion between the new Darvocet A500 and Darvocet-N 100
Medication Errors Look- and sound-alike drug names are creating mistakes